Sleep Study Results Explained: Understanding Your Report

A polysomnography report is a detailed medical document that summarizes hundreds of pages of raw physiological data into clinically meaningful metrics. Understanding the key components empowers you to have more productive conversations with your sleep physician about your diagnosis and treatment.

Your report typically contains the following major sections:

• Patient demographics and study information: Your identifying details, the date of the study, total recording time, total sleep time, and the type of study performed.
• Sleep architecture summary: Total sleep time, sleep efficiency, sleep onset latency, REM latency, and the percentage of time spent in each sleep stage.
• Respiratory event summary: The core diagnostic data including your Apnea-Hypopnea Index (AHI), Respiratory Disturbance Index (RDI), oxygen desaturation metrics, and breakdown of event types (obstructive, central, mixed, hypopneas).
• Cardiac and movement data: Average and range of heart rate, any arrhythmias detected, periodic limb movement index (PLMI), and arousal index with categorization by cause.
• Interpretation and diagnosis: The sleep physician's clinical assessment, formal diagnostic conclusions based on ICSD-3 criteria, and severity classification.
• Recommendations: Suggested next steps including treatment initiation, additional testing, specialist referrals, or follow-up scheduling.

Results are typically available 1 to 3 weeks after your study. A registered polysomnographic technologist first scores the raw data—manually identifying each 30-second epoch's sleep stage, marking every respiratory event, and cataloging limb movements and arousals. The board-certified sleep medicine physician then reviews this scoring, correlates findings with your clinical history, and writes the formal interpretation.

When you receive your report, do not be overwhelmed by the medical terminology. Focus on the key diagnostic metrics explained below, and use your follow-up appointment to ask questions about anything you do not understand. The physician's "Interpretation" and "Recommendations" sections contain the most actionable clinical conclusions.

The Apnea-Hypopnea Index (AHI) is the single most important number in your sleep study report for diagnosing sleep apnea. It represents the average number of apneas and hypopneas per hour of sleep. An apnea is a complete cessation of airflow lasting at least 10 seconds. A hypopnea is a partial reduction in airflow of at least 30%, lasting at least 10 seconds, associated with either an oxygen desaturation of 3% or more or an arousal from sleep.

AHI Severity Classification

• Normal: AHI less than 5 — Fewer than 5 breathing events per hour of sleep. This is considered within normal limits for adults. Some breathing irregularity during sleep is physiologically normal, particularly during transitions between sleep stages.
• Mild obstructive sleep apnea: AHI 5 to 15 — Five to fifteen events per hour. Treatment is recommended when significant symptoms are present (excessive daytime sleepiness, impaired cognitive function) or cardiovascular risk factors exist. Options include positional therapy, oral appliances, or CPAP.
• Moderate obstructive sleep apnea: AHI 15 to 30 — Fifteen to thirty events per hour. Treatment is strongly recommended regardless of symptom burden, as cardiovascular risk increases substantially. CPAP therapy is the first-line treatment.
• Severe obstructive sleep apnea: AHI greater than 30 — More than thirty breathing disruptions per hour. This substantially increases cardiovascular risk and profoundly impairs quality of life. CPAP therapy is the standard of care, and treatment should be initiated promptly.

Event Type Classification

Your report distinguishes between obstructive events (the airway physically collapses despite continued breathing effort), central events (the brain temporarily fails to signal the respiratory muscles), and mixed events (beginning as central and transitioning to obstructive). This distinction is critical because each type requires different therapy.

The AHI may also be reported separately for different body positions (supine versus lateral) and sleep stages (REM versus NREM). Sleep apnea commonly worsens by 50% or more when sleeping on the back and during REM sleep due to gravity effects and reduced muscle tone respectively.

Position-dependent sleep apnea is defined as a supine AHI at least twice the non-supine AHI. Patients with this pattern may respond to positional therapy alone in mild cases—devices that discourage back sleeping can effectively reduce overall AHI without requiring CPAP.

The Oxygen Desaturation Index measures how frequently your blood oxygen saturation drops during sleep. Specifically, it counts the number of times per hour that your SpO2 falls by 3% or more from baseline (some laboratories use a 4% threshold). This metric captures the physiological impact of respiratory events on oxygen delivery to tissues and organs.

Key Oxygen Metrics in Your Report

• Baseline SpO2: Your resting oxygen saturation while awake and breathing normally, typically 95-100% in healthy adults at sea level.
• Mean SpO2 during sleep: Your average oxygen saturation across the entire recording. Values below 93% suggest clinically meaningful nocturnal hypoxemia.
• Minimum SpO2 (nadir): The single lowest oxygen reading recorded. Values below 88% are clinically significant; values below 80% indicate severe desaturation.
• Time below 90% SpO2 (T90): The total minutes spent with oxygen below 90%. Extended time below this threshold (greater than 5% of total sleep time) is independently associated with cardiovascular morbidity.
• ODI (3% or 4%): The frequency of desaturation events per hour of sleep.

The ODI often correlates closely with the AHI, since most apneas and hypopneas produce oxygen drops. However, important discrepancies exist: some patients have a high AHI with preserved oxygen because their events are brief, while others have fewer events but prolonged severe desaturations.

Chronic nocturnal hypoxemia is independently associated with pulmonary hypertension, cardiac arrhythmias (particularly atrial fibrillation), cognitive impairment, insulin resistance, and increased mortality. The severity of oxygen desaturation influences treatment urgency and therapy type.

In some cases, patients with a borderline AHI may still warrant treatment if oxygen desaturation is severe—for example, prolonged periods below 85%. Conversely, patients with elevated AHI but minimal oxygen impact may have more flexibility in choosing between treatment options.

Sleep efficiency is the percentage of time you actually spent asleep compared to the total time in bed. It provides a quantitative measure of how consolidated your sleep was during the study.

• Normal sleep efficiency: 85% or higher in a sleep laboratory. In your own home, normal efficiency is typically 90% or higher. The lab environment routinely reduces efficiency by 5-10%.
• Reduced sleep efficiency (70-85%): May reflect the "first-night effect," clinical insomnia, pain, or frequent arousals from respiratory events or limb movements.
• Poor sleep efficiency (below 70%): Suggests significant sleep disruption. Your physician will consider whether this reflects a primary sleep disorder or the lab setting.

Sleep Onset Latency

Sleep onset latency measures minutes from lights-out to sustained sleep. Normal is 10 to 20 minutes. Very short latency (under 5 minutes) suggests excessive sleepiness and significant sleep debt. Very long latency (over 30 minutes) may indicate insomnia or anxiety about testing.

REM Latency

REM latency measures time from sleep onset to first REM period. Normal is 70 to 120 minutes. Abnormally short REM latency (under 15 minutes) is a hallmark of narcolepsy type 1 and may also occur with REM-rebound after sleep deprivation or medication withdrawal.

Your physician interprets these timing metrics in the context of your clinical history and medication use. A single night in the laboratory may not perfectly represent your typical sleep.

The "first-night effect" is well-documented: patients sleep less efficiently in unfamiliar environments. Your physician accounts for this when interpreting borderline results. If sleep efficiency was notably poor, a repeat study or home test may be recommended to confirm findings.

Your report breaks down total sleep time into distinct stages, each identified by characteristic brain wave patterns on EEG. Understanding what each stage represents helps you interpret whether your sleep architecture is normal or disrupted.

Stage N1 (Light Sleep / Drowsiness)

The brief transition between wakefulness and sleep. N1 typically comprises 2-5% of total sleep time. An increased percentage (greater than 10%) suggests fragmented sleep, as the brain repeatedly returns to this transitional stage after arousals. Elevated N1 is commonly seen in untreated sleep apnea.

Stage N2 (Intermediate Sleep)

The dominant stage, normally 45-55% of total sleep time. Characterized by sleep spindles and K-complexes on EEG. Important for memory consolidation and neural maintenance. N2 percentage is usually within normal range even in patients with significant sleep disorders.

Stage N3 (Deep Sleep / Slow-Wave Sleep)

The most physically restorative stage, normally 15-25% in young adults but decreasing with age. Essential for physical recovery, immune function, growth hormone release, and tissue repair. Reduced N3 is associated with unrefreshing sleep and may be seen in chronic insomnia, fibromyalgia, and aging.

Stage REM (Rapid Eye Movement)

Normally 20-25% of total sleep time. Critical for emotional regulation, memory processing, and learning. Characterized by rapid eye movements, near-complete muscle atonia, and vivid dreaming. Sleep apnea frequently worsens during REM because muscle atonia extends to the upper airway, increasing collapse susceptibility.

Your sleep physician evaluates whether your stage distribution is appropriate for your age and whether treating identified sleep disorders is likely to normalize your sleep architecture over time. Patients with untreated severe sleep apnea often show reduced REM and N3 with elevated N1. After successful CPAP treatment, many experience "REM rebound" as the brain recovers previously lost restorative sleep.

The arousal index quantifies how many times per hour your brain briefly shifts from deeper sleep to lighter sleep or wakefulness without you being consciously aware. These microarousals (lasting 3 to 15 seconds) fragment sleep continuity and prevent restorative deep sleep.

• Normal arousal index: Fewer than 10 per hour in younger adults, up to 15-20 in older adults.
• Mildly elevated: 15 to 25 per hour. May cause some daytime symptoms.
• Significantly elevated: Greater than 25 per hour. Associated with marked daytime sleepiness, cognitive impairment, and reduced quality of life.

Arousals are categorized by trigger: respiratory (caused by apneas or hypopneas), limb movement-related, spontaneous (no identifiable trigger), or technical (equipment or environmental factors). This breakdown helps prioritize treatment targets.

Periodic Limb Movement Index (PLMI)

The PLMI measures repetitive, stereotyped leg movements during sleep—typically rhythmic dorsiflexion of the ankle and toe. These movements last 0.5 to 10 seconds and repeat in clusters every 5 to 90 seconds.

• Normal PLMI: Fewer than 15 movements per hour of sleep.
• Elevated PLMI: Greater than 15 per hour. When associated with arousals and symptoms (unrefreshing sleep, daytime fatigue, restless legs), this supports a diagnosis of Periodic Limb Movement Disorder (PLMD).

The PLMI with arousal (PLMAI)—counting only movements that trigger cortical arousal—is more clinically relevant than total PLMI. Many limb movements occur without disrupting sleep. Periodic limb movements commonly coexist with restless legs syndrome, sleep apnea, iron deficiency, and certain medications. Treatment may include addressing underlying causes, iron supplementation, or medications such as gabapentin or low-dose dopamine agonists.

Once your sleep study results are fully interpreted, your sleep physician discusses findings at a follow-up appointment and recommends a treatment plan tailored to the type and severity of disorder identified.

If You Have Obstructive Sleep Apnea

• Mild OSA (AHI 5-15): Options depend on symptom severity and include positional therapy, weight management, oral appliance therapy, or CPAP for patients who prefer it or have significant symptoms.
• Moderate to severe OSA (AHI greater than 15): Positive airway pressure therapy (CPAP or APAP) is the first-line recommendation. A titration study or auto-adjusting device may be prescribed.

If You Have Central Sleep Apnea

Central sleep apnea requires different treatment approaches, potentially including adaptive servo-ventilation (ASV), bilevel PAP with a backup rate, supplemental oxygen, or treatment of the underlying condition (heart failure, opioid use, altitude adjustment).

If Results Are Normal

A normal study definitively rules out sleep apnea and periodic limb movement disorder. Your physician will explore alternative explanations such as insufficient sleep syndrome, circadian rhythm disorders, mood disorders, or primary insomnia, and may recommend additional testing or behavioral interventions.

Follow-Up Timeline

After initiating treatment, most sleep physicians schedule follow-up at 1 to 3 months to assess adherence, review device data, evaluate symptom improvement, and adjust settings. Long-term annual follow-up ensures ongoing treatment success and monitors for changes in severity.